| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
2,583,000
|
2,463,000
|
2,414,000
|
2,149,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
2,583,000
|
2,463,000
|
2,414,000
|
2,149,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 2,799,000 | 2,778,000 | 2,688,000 | 2,667,000 |
|
Non Recurring | 179,000 | 197,000 | 153,000 | 505,000 |
|
Others | 62,000 | 35,000 | 90,000 | 78,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(341,000)
|
(457,000)
|
(395,000)
|
(993,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 146,000 | 137,000 | 151,000 | 152,000 |
|
Earnings Before Interest And Taxes | 905,000 | 971,000 | 1,103,000 | 730,000 |
|
Interest Expense | 96,000 | 118,000 | 128,000 | 141,000 |
|
Income Before Tax | 809,000 | 853,000 | 975,000 | 589,000 |
|
Income Tax Expense | 1,046,000 | 207,000 | 225,000 | 93,000 |
|
Minority Interest | (16,000) | (11,000) | (25,000) | (30,000) |
|
|
|
Net Income From Continuing Ops | (253,000) | 713,000 | 725,000 | 466,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(253,000)
|
635,000
|
725,000
|
466,000
| | Preferred Stock And Other Adjustments | (13,000) | (13,000) | (5,000) |
-
| | |
Net Income Applicable To Common Shares
|
(266,000)
|
622,000
|
720,000
|
466,000
|
|